{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["64"],"submitter":["Wee LE"],"pubmed_abstract":["<h4>Background</h4>DENV-infection and SARS-CoV-2 are now endemic in tropical regions; interactions may exist, given antigenic cross-reactivity and cross-protection. Risk of subsequent DENV-infection following prior COVID-19 was evaluated in a population-based adult cohort.<h4>Methods</h4>Retrospective cohort study including all Singaporeans ≥18 years. National registries were used to construct contemporaneous SARS-CoV-2-infected/test-negative cohorts from 1st Sept 2021-31st Dec 2022 during Delta/Omicron emergence. COVID-19 vaccination status was classified using the national-immunization-registry. Risk of DENV-infection recorded in the national registry 31-300 days post-COVID-19 was contrasted against test-negatives using overlap-weighted Cox regression. Risk of other infections (invasive-"],"journal":["The Lancet regional health. Western Pacific"],"pagination":["101727"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12639892"],"repository":["biostudies-literature"],"pubmed_title":["Risk of dengue following prior SARS-CoV-2 infection: a population-based cohort study."],"pmcid":["PMC12639892"],"pubmed_authors":["Lim JT","Ma P","Lye DC","Wee LE","Chia PY","Tay AT","Dickens B","Ng LC","Leo YS","Tan KB","Chiew C"],"additional_accession":[]},"is_claimable":false,"name":"Risk of dengue following prior SARS-CoV-2 infection: a population-based cohort study.","description":"<h4>Background</h4>DENV-infection and SARS-CoV-2 are now endemic in tropical regions; interactions may exist, given antigenic cross-reactivity and cross-protection. Risk of subsequent DENV-infection following prior COVID-19 was evaluated in a population-based adult cohort.<h4>Methods</h4>Retrospective cohort study including all Singaporeans ≥18 years. National registries were used to construct contemporaneous SARS-CoV-2-infected/test-negative cohorts from 1st Sept 2021-31st Dec 2022 during Delta/Omicron emergence. COVID-19 vaccination status was classified using the national-immunization-registry. Risk of DENV-infection recorded in the national registry 31-300 days post-COVID-19 was contrasted against test-negatives using overlap-weighted Cox regression. Risk of other infections (invasive-","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Nov","modification":"2026-06-05T19:49:39.462Z","creation":"2026-05-21T03:10:48.95Z"},"accession":"S-EPMC12639892","cross_references":{"pubmed":["41281901"],"doi":["10.1016/j.lanwpc.2025.101727"]}}